Improving Lives Through Research®

Public Health & Epidemiology

Westat’s interdisciplinary public health and epidemiology sector uses an evidence-based approach to prevent and detect diseases, injuries, and other conditions in order to improve health outcomes. Our success is reflected in the contributions our clients make to advancements in preventing, diagnosing, and treating infectious and chronic diseases, particularly among vulnerable populations. Our public health staff have expertise in surveillance, program interventions, communication, evaluation, and research.

Featured

Westat’s Terry Savage on Challenges with COVID-19 Communications

Read The Feature

See how we can answer questions like...

Does cancer screening save lives?

What factors lead to elevated glycemia and, ultimately, diabetes?

What are the current feeding practices of infants and toddlers?

See More Projects

Public Health & Epidemiology Leadership

Patricia Shifflett
Patricia Shifflett
Vice President & Practice Director

Meet our Experts

360+

Projects

160

Staff

200

Recent Publications

News

Public Health & Epidemiology

Westat Supports Largest Nationwide SARS-CoV-2 Seroprevalence Survey

Public Health & Epidemiology

Westat to Provide Health Marketing Support for Let’s Stop HIV Together Initiative

Data Collection & Survey Research

Dietary Data Collection and Analysis: Westat @ 2020 National Nutrient Databank Conference

See More News

Publications

Yount N., Zebrak K.A., Famolaro T., Sorra J., and Birch R. (2020).

Linking patient safety culture to quality ratings in the nursing home setting.

Journal of Applied Gerontology.
DOI | PubMed
Casagrande S.S., Lessem S.E., Orchard T.J., Bullard K.M., Geiss L.S., Saydah S.H., Menke A., Imperatore G., Rust K.F., and Cowie C.C. (2020).

A comparison of several survey-based algorithms to ascertain type 1 diabetes among U.S. adults with self-reported diabetes.

British Medical Journal Open Diabetes Research & Care.
Lindenberg L., Mena E., Turkbey B., Shih J.H., Reese S.E., Harmon S.A., Lim I., Lin F., Ton A., McKinney Y.L., Eclarinal P., Citrin D.E., Dahut W., Madan R., Wood B.J., Krishnasamy V., Chang R., Levy E., Pinto P., Eary J.F., and Choyke P.L. (2020).

Evaluating biochemically recurrent prostate cancer: Histologic validation of 18F-DCFPyL PET/CT with comparison to multiparametric MRI.

Radiology, 296(3), 564-572.
DOI | PubMed

See More Publications

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Substance Abuse and Mental Health Services Administration
The National Institutes of Health
AAA Foundation for Traffic Safety
The Johns Hopkins University
University of Maryland Baltimore Campus
University of Denver
U.S. Department of Veterans Affairs
U.S. Department of Transportation
U.S. Department of Justice
U.S. Department of Health and Human Services
U.S. Department of Education
U.S. Department of Agriculture
Toyota
The Verizon Foundation
Texas Education Agency
Baltimore Metropolitan Council
Teach for America
Social Security Administration
SiriusXM
Robert Wood Johnson Foundation
Organization for Economic Cooperation and Development
NYC Mayor’s Office for Economic Opportunity
National Science Foundation
Michigan Department of Health and Human Services
Maryland Cancer Registry
Internal Revenue Service
Georgia Department of Transportation
DC Public Schools
ClearWay Minnesota
Chicago Metropolitan Agency for Planning
University of Michigan
Explore Our Clients

Please wait...

Forbes 2020 The Best Employers for Diversity Powered by Statista Copyright 2019 Forbes Media LLC. Used with permissionForbes 2019: The Best Employers for Women Powered by Statista Copyright 2019 Forbes Media LLC. Used with permission

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.